Clinical Trial Update: Nivolumab Plus Radiotherapy in Advanced Melanoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update of nivolumab plus radiotherapy in advanced melanoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• nivolumab (nivolumab)

Snippet

Sponsor: Centre Hospitalier Universitaire de Nice | Conditions: Melanoma | Phase 2 | Status: COMPLETED